BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9304763)

  • 1. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes.
    Shih WJ; Zhao PL
    Stat Med; 1997 Sep; 16(17):1913-23. PubMed ID: 9304763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change.
    Shih WJ; Gould AL
    Stat Med; 1995 Oct; 14(20):2239-48. PubMed ID: 8552900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size re-estimation for survival data in clinical trials with an adaptive design.
    Togo K; Iwasaki M
    Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
    Friede T; Kieser M
    Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size re-estimation incorporating prior information on a nuisance parameter.
    Mütze T; Schmidli H; Friede T
    Pharm Stat; 2018 Mar; 17(2):126-143. PubMed ID: 29181869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample Size Re-Estimation without Breaking the Blind in Clinical Trial.
    Wu CH
    J Biopharm Stat; 2015; 25(5):1114-29. PubMed ID: 25630031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the sample size at interim for a two-sample experiment without Type I error inflation.
    Dunnigan K; King DW
    Pharm Stat; 2010; 9(4):280-7. PubMed ID: 19764040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive statistical analysis following sample size modification based on interim review of effect size.
    Hung HM; Cui L; Wang SJ; Lawrence J
    J Biopharm Stat; 2005; 15(4):693-706. PubMed ID: 16022173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SAS macro for sample size adjustment and randomization test for internal pilot study.
    Wang S; Xia J; Yu L; Li C; Xu L
    Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Information-based sample size re-estimation in group sequential design for longitudinal trials.
    Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
    Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A SAS macro for sample size re-estimation.
    Zellner D; Zellner GE; Keller F
    Comput Methods Programs Biomed; 2001 Jun; 65(3):183-90. PubMed ID: 11339980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size determination and re-estimation for matched pair designs with multiple binary endpoints.
    Xu J; Yu M
    Biom J; 2013 May; 55(3):430-43. PubMed ID: 23553605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size re-estimation: recent developments and practical considerations.
    Gould AL
    Stat Med; 2001 Sep 15-30; 20(17-18):2625-43. PubMed ID: 11523073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-stage sample size re-estimation based on a nuisance parameter: a review.
    Proschan MA
    J Biopharm Stat; 2005; 15(4):559-74. PubMed ID: 16022163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded sample size recalculation in clinical trials with binary composite endpoints.
    Sander A; Rauch G; Kieser M
    J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of the two-sample t-test statistic following blinded sample size re-estimation.
    Lu K
    Pharm Stat; 2016 May; 15(3):208-15. PubMed ID: 26865383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.